To determine the safety, efficacy and toxicity of using cord blood as a source for stem cell transplantation in patients with hematologic malignancies. weekly until day 100+, then yearly [clinicaltrials_resource:9ae882fb4c8ee5b3ba16f66ce05c6eb3]
IV
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To determine the safety, efficacy and toxicity of using cord blood as a source for stem cell transplantation in patients with hematologic malignancies. weekly until day 100+, then yearly [clinicaltrials_resource:9ae882fb4c8ee5b3ba16f66ce05c6eb3]
IV
Bio2RDF identifier
9ae882fb4c8ee5b3ba16f66ce05c6eb3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9ae882fb4c8ee5b3ba16f66ce05c6eb3
measure [clinicaltrials_vocabulary:measure]
To determine the safety, effic ...... with hematologic malignancies.
time frame [clinicaltrials_vocabulary:time-frame]
weekly until day 100+, then yearly
description
identifier
clinicaltrials_resource:9ae882fb4c8ee5b3ba16f66ce05c6eb3
title
To determine the safety, effic ...... ly until day 100+, then yearly
@en
type
label
To determine the safety, effic ...... 882fb4c8ee5b3ba16f66ce05c6eb3]
@en